ENDOD1 and prostate carcinoma: The final protein identified with altered expression in the contralateral cortex was endonuclease domain-containing 1 protein (Endod1), which functions as a tumor suppressor, particularly in prostate cancer, and is implicated in innate immune responses (Qiu et al. 2017).